| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.31 | 2e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0007 |